COX-2 inhibitors as adjunctive therapy in schizophrenia

Author： Müller Norbert Strassnig Martin Schwarz Markus J Ulmschneider Markus Riedel Michael

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.8, 2004-08, pp. : 1033-1044

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

COX-2 Inhibitors as Adjunctive Therapy in Schizophrenia: Rationale for Use and Evidence to Date

By Riedel Michael

CNS Drugs, Vol. 19, Iss. 10, 2005-01 ,pp. : 805-819

Adis International

Access to resources Recommend Favorite

Cholinesterase Inhibitors as Adjunctive Therapy in Patients with Schizophrenia and Schizoaffective Disorder: A Review and Meta-Analysis of the Literature

By Ribeiz Salma R.I.

CNS Drugs, Vol. 24, Iss. 4, 2010-04 ,pp. : 303-317

Adis International

Access to resources Recommend Favorite

Back to the Future: COX-2 Inhibitors for Chemoprevention and Cancer Therapy

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 6, 2007-06 ,pp. : 599-608

Bentham Science Publishers

Access to resources Recommend Favorite

COX-2 inhibitors

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 9, 2003-09 ,pp. : 1465-1468

Informa Healthcare

Access to resources Recommend Favorite

Disturbance of vision by COX-2 inhibitors

By Coulter David M Clark David WJ

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 607-614

Informa Healthcare

Access to resources Recommend Favorite